• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

PACS firms better watch out for Y2K

Article

PACS firms better watch out for Y2KThe year 2000 (Y2K) issue has led to much concern in the PACS and medical imaging market, for both vendors and end users alike. Non-Y2K-compliant systems in the field will provide tension between vendors and

PACS firms better watch out for Y2K

The year 2000 (Y2K) issue has led to much concern in the PACS and medical imaging market, for both vendors and end users alike. Non-Y2K-compliant systems in the field will provide tension between vendors and their clients, if they haven't already (see article on SCAR meeting, page 4).

While many customers expect that vendors will foot the bill for solving the problem, companies have often been reluctant to assume the cost for equipment that in many cases was not expected to last into the millennium. It's altogether possible that disputes over this issue may wind up in court.

The biggest impact of Y2K on PACS firms, however, may be on future PACS purchases. The problem is absorbing an increasing percentage of hospital information technology budgets. With many IT resources focused on Y2K, big-ticket purchases like PACS will likely be placed on hold.

In this kind of environment, PACS vendors, many of which are adding dramatically to their organizations, may experience a substantial slowdown in sales in the second half of the year and through 1999. If this happens, it would be truly unfortunate, because the market fundamentals for strong growth in the PACS sector finally appear to be
in place.

In other developments, PACS & Networking News is launching a new feature this month. Contributed periodically by consultant Herman Oosterwijk, DICOM Update will keep you abreast of ongoing developments with the DICOM standard.

-Erik L. Ridley, Editor

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.